Ann: Investment from Sichuan Hebang Biotechnology, page-6

  1. 2,039 Posts.
    lightbulb Created with Sketch. 867
    "the Placement will raise A$7.567 million through the issue of 1,081,000,000shares at an issue price of $0.007 per share. This issue will result in Hebang having increasing itsinterest in the issued capital of the Company to 49%"

    according to grok it's actually 49.93%, not leaving any room for further dilution without handing over full operational control. If Hebang push for 100% ownership, AEV could face being delisted (ASX listing Rule 17.12) so hopefull they use the funds to fast-track Wonnara development instead of frittering away millions on 'Operational expenses'.
    Fingers xd.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.001(11.1%)
Mkt cap ! $31.77M
Open High Low Value Volume
0.9¢ 1.0¢ 0.9¢ $2.311K 251.1K

Buyers (Bids)

No. Vol. Price($)
5 3128741 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 7515696 13
View Market Depth
Last trade - 15.57pm 27/06/2025 (20 minute delay) ?
AEV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.